Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
about
Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis.Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry.Coagulation and cancer: biological and clinical aspects.Splanchnic vein thrombosis in myeloproliferative neoplasms.Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options.Thromboembolic risk in hematological malignancies.Age-Related Macular Degeneration in Patients With Chronic Myeloproliferative Neoplasms.Haemostatic Profile in Patients of Myeloproliferative Neoplasms-A Tertiary Care Centre Experience.Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy.Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis.Myocardial infarction as a thrombotic complication of myeloproliferative disorders.An Overview of Thrombophilia and Associated Laboratory Testing.Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients.Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging.Paraneoplastische Gerinnungsstörungen
P2860
Q30235926-4FE3CB55-0427-4AAF-81E1-511DDA24D191Q36654317-A26C293B-8441-4BEE-8F14-0BCED023F742Q38070918-DDF08BEC-71D1-4878-B254-0F078C595757Q38121635-D2A29E9E-2E0C-4634-9CA3-95108BD33794Q38255717-7A4FF7B0-0EC5-4C6A-9D33-F7F59337DCF4Q38287304-28B05CF0-67D3-44D4-9614-E7C2076B7274Q38706624-7F61F081-36AD-41DF-AAA7-9516499C9BC8Q40074413-7F0101C6-822C-4605-9353-B85DDA916D22Q41553988-93321F55-EFA2-47B4-9484-94C27B6F4649Q41693572-77B80E5F-0984-4681-99A6-F564C7C3A645Q42319131-1A6E9C69-6FE5-4443-98DC-78D70B266224Q47957644-93B66152-FE58-4DB5-B1AF-211F71FA4388Q48248231-35CDB723-F6F3-4244-B00B-C25326FD1C44Q48509408-E727CE7D-75DD-429A-8F4C-95D09914E9BBQ58023686-07466DF2-9A52-4B08-9F3D-1E9C4AB3E6BC
P2860
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
@ast
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
@en
type
label
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
@ast
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
@en
prefLabel
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
@ast
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
@en
P2860
P356
P1433
P1476
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2011.314
P577
2011-11-11T00:00:00Z
P5875
P6179
1044168491